Almac Group to host Clinical Trial Supply Lunch and Learn Workshop in San Francisco

February 20, 2019

Souderton, PA, U.S, 20 February 2019Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization, the Almac Group, is delighted to invite participants from the Biopharma Industry to join its upcoming lunch and learn workshop in San Francisco, CA.

Hosted at Doubletree Suites by Hilton San Francisco Airport North on Wednesday, March 27th, the complimentary workshop will examine “Clinical Trial Supply and Technology: A proven approach to achieve supply chain harmony”. Leading the workshop will be Almac’s clinical supply experts, including Jacqueline Masker, Supply Chain Manager, Project Leader Cheryl Kole, Director of Technical Solutions, and Andy Ritchey, Supply Chain Manager.

Almac understands the challenges faced by biotechnology and pharmaceutical companies in an ever-changing industry. Using real life case studies and interactive discussion, the workshop will follow the life cycle of the physical clinical supply chain from bulk manufacture to destruction, demonstrating the effective use of integrated digital systems for site, drug and patient management. Attendees will learn how to achieve an optimized and harmonized clinical supply chain as well as discuss how to overcome the barriers posed by the management of clinical supplies. 

Workshop speaker, Cheryl Kole, comments on the upcoming event:

“We are excited to be hosting this unique workshop which will give participants an opportunity to understand Almac’s extensive clinical supply capabilities. The primary goal of this workshop is for attendees to leave with a wealth of knowledge on how to execute their trials more effectively based on a solid understanding of having a harmonized physical and digital clinical supply chain.”

As industry leading experts, Almac hopes that the information presented during this complimentary lunch and learn workshop can help to guide clinical supply professionals throughout their clinical supply journey. 

To find out more and to sign up, please visit:


About Almac Group 
A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialization, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organization which has grown organically over the past five decades now employing over 5600 highly skilled personnel across 17 facilities including Europe, the US and Asia.

The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

To keep up to date with latest news, follow Almac Group on Twitter and LinkedIn


Back to news